
#ESWI2025
20-23 October 2025, Valencia
Register now!
A PeerVoice symposium supported by an educational grant from Moderna)
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam ac mauris ac felis cursus lobortis non dignissim neque. Morbi volutpat luctus ante, id accumsan erat vestibulum a. Quisque in placerat lorem. In dui lectus, tincidunt vitae odio in, condimentum vulputate eros. Vestibulum in rhoncus tortor. Phasellus et eros justo. Nam aliquet egestas nunc, id feugiat sem interdum vel. In vitae ligula malesuada, vulputate nulla id, venenatis sem. Cras auctor magna et molestie aliquet. Aenean sit amet finibus justo, at bibendum leo. Donec eu neque tortor.
Curabitur dolor leo, venenatis commodo ultricies et, consequat vulputate odio. Curabitur et diam a neque lobortis vehicula vel eget augue. Pellentesque massa orci, scelerisque non placerat in, volutpat nec quam. Morbi et tempus enim, rhoncus blandit nibh. Phasellus ut odio condimentum lacus accumsan iaculis. Ut porta massa quis erat fringilla, non finibus ligula vestibulum. Curabitur molestie mauris urna, id accumsan nulla pulvinar nec. Aenean quis vestibulum metus. Nunc dictum tellus ut purus vestibulum pulvinar.
Nationality: American, British
Position: Professor of Applied Evolutionary Biology, University of Amsterdam Faculty of Medicine
Research field: Virus Evolution
ESWI member since 2019
Colin Russell is a professor at the University of Amsterdam School of Medicine. His research focuses on the evolutionary dynamics of human respiratory viruses and the immune responses that control them. He has worked extensively on the within-and-between host evolution of influenza viruses, influenza virus vaccine composition, and issues related to diagnostic and sequencing resource allocation for virus surveillance. Professor Russell regularly advises a wide variety of international organisations, including WHO, on topics ranging from surveillance to pandemic preparedness, vaccine design, and test-to-treat programs. Colin is the Chair of the ESWI since 2023 and the Chair of the EU Steering Group on Influenza Vaccination since 2024.